Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo

被引:55
|
作者
Kim, Jinhee [1 ]
Lee, Hyejin [1 ]
Kang, Ki Sung [2 ]
Chun, Kwang-Hoon [3 ]
Hwang, Gwi Seo [1 ,2 ]
机构
[1] Gachon Univ, Coll Korean Med, Lab Cell Differentiat Res, Gyeonggi Do 461701, Seongnam, South Korea
[2] Gachon Univ, Coll Korean Med, Gyeonggi Do 461701, Seongnam, South Korea
[3] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Inchon, South Korea
关键词
dexamethasone; Korean Red Ginseng; osteoblast; osteoporosis; Panax ginseng; PANAX-GINSENG; POTENTIAL MECHANISMS; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; BONE; OSTEOBLASTS; INHIBITION; PREVENTION; OSTEOCYTES; RATS;
D O I
10.1016/j.jgr.2014.06.001
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Glucocorticoids (GCs) are commonly used in many chemotherapeutic protocols and play an important role in the normal regulation of bone remodeling. However, the prolonged use of GCs results in osteoporosis, which is partially due to apoptosis of osteoblasts and osteocytes. In this study, effects of Korean Red Ginseng (KRG) on GC-treated murine osteoblastic MC3T3-E1 cells and a GC-induced osteoporosis mouse model were investigated. Methods: MC3T3-E1 cells were exposed to dexamethasone (Dex) with or without KRG and cell viability was measured by the 344, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Real-time polymerase chain reaction was performed to evaluate the apoptotic gene expression; osteogenic gene expression and alkaline phosphatase (ALP) activity were also measured. Western blotting was performed to evaluate the mitogen-activated protein kinase (MAPK) proteins. A GC-induced osteoporosis animal model was used for in vivo study. Results and conclusion: The MU assay revealed that Korean Red Ginseng (KRG) prevents loss of cell viability caused by Dex-induced apoptosis in MC3T3E1 cells. Real-time polymerase chain reaction data showed that groups treated with both Dex and KRG exhibited lower mRNA levels of caspase-3 and -9, whereas the mRNA levels of Bcl2, IAPs, and XIAP increased. Moreover, groups treated with both Dex and KRG demonstrated increased mRNA levels of ALP. RUNX2, and bone morphogenic proteins as well as increased ALP activity in MC3T3-E1 cells, compared to cells treated with Dex only. In addition, KRG increased protein kinase B (AKT) phosphorylation and decreased c-Jun N-terminal kinase (JNK) phosphorylation. Moreover, microcomputed tomography analysis of the femurs showed that GC implantation caused trabecular bone loss. However, a significant reduction of bone loss was observed in the KRG-treated group. These results suggest that the molecular mechanism of KRG in the GC-induced apoptosis may lead to the development of therapeutic strategies to prevent and/or delay osteoporosis. Copyright (C) 2014. The Korean Society of Ginseng. Published by Elsevier. All rights reserved.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [31] Glucocorticoid-induced osteoporosis
    Sambrook, Philip N.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2008, 11 (04) : 381 - 385
  • [32] Glucocorticoid-induced osteoporosis
    Saag, KG
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2003, 32 (01) : 135 - +
  • [33] Effects of Siberian Ginseng Extract and Ipriflavone on the Development of Glucocorticoid-Induced Osteoporosis
    A. V. Kropotov
    O. L. Kolodnyak
    V. M. Koldaev
    Bulletin of Experimental Biology and Medicine, 2002, 133 : 252 - 254
  • [34] Effects of Siberian ginseng extract and ipriflavone on the development of glucocorticoid-induced osteoporosis
    Kropotov, AV
    Kolodnyak, OL
    Koldaev, NM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 133 (03) : 252 - 254
  • [35] Glucocorticoid-induced osteoporosis
    den Uyl, D.
    Bultink, I. E. M.
    Lems, W. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : S93 - S98
  • [36] Glucocorticoid-induced osteoporosis
    Kennedy, Courtney C.
    Papaioannou, Alexandra
    Adachi, Jonathan D.
    WOMENS HEALTH, 2006, 2 (01) : 65 - 74
  • [37] Glucocorticoid-induced Osteoporosis
    Whittier, Xena
    Saag, Kenneth G.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 177 - +
  • [38] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    BAYLINK, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (05): : 306 - 308
  • [39] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Lorena Brance, Maria
    Brun, Lucas R.
    REVISTA MEDICA DE ROSARIO, 2008, 74 (02): : 78 - 88
  • [40] Glucocorticoid-induced osteoporosis
    Briot, Karine
    Roux, Christian
    RMD OPEN, 2015, 1 (01):